COVID-19 Vaccination Information

Pfizer-BioNTech Vaccine :

• Approved for ages 16+
• Two-doses, 21 days apart

Moderna Vaccine :

• Approved for ages 18+
• Two-doses, 28 days apart

Co-administration with other vaccines :

• The COVID-19 series should be administered alone
• The COVID-19 vaccine should be administered a minimum of 14 days before or after other vaccinations

Persons with current or prior history of COVID-19 infection :

• Trials indicate the mRNA COVID-19 vaccines are safe for persons with evidence of a prior COVID-19 infection
• Vaccinations should be offered regardless of history of prior symptomatic or asymptomatic infection
• Vaccination of persons with current COVID-19 infection should be deferred until recovery from the acute illness and criteria have been met to discontinue isolation

Persons with a known COVID-19 exposure should not seek vaccination until their quarantine period has ended

• Residents with a known COVID-19 exposure living in congregate healthcare settings (e.g., long-term care facilities), where exposure and transmission of SARS-CoV-2 can occur repeatedly for long periods of time, may be vaccinated
• Residents of other congregate settings (e.g., correctional and detention facilities, homeless shelters) with a known COVID-19 exposure may also be vaccinated

Persons who previously received passive antibody therapy :

• Based on current evidence, reinfection is uncommon in the 90 days after initial infection
• Vaccination should be deferred for at least 90 days as a precautionary measure

Observation Period :

• The CDC recommends 15 minute observation period following COVID-19 vaccinations
• For those with a history of anaphylaxis, a 30 minute observation period is recommended

Vaccination during Pregnancy & Lactation :

• COVID-19 mRNA vaccinations were not tested on pregnant or lactating persons; there is no safety data available for these groups
• A lactating person who is part of a group recommended to receive a COVID-19 vaccine (e.g., healthcare personnel) may choose to be vaccinated
• If pregnant people are part of a group that is recommended to receive a COVID-19 vaccine (e.g., healthcare personnel), they may choose to be vaccinated.
• A conversation between the patient and their clinical team may assist with decisions regarding the use of a mRNA COVID-19 vaccine, though a conversation with a healthcare provider is not required prior to vaccination
• When making a decision, pregnant people and their healthcare providers should consider:
  • The level of COVID-19 community transmission
  • The patient’s personal risk of contracting COVID-19,
  • The risks of COVID-19 to the patient and potential risks to the fetus,
  • The efficacy of the vaccine,
  • The side effects of the vaccine, and
  • The lack of data about the vaccine during pregnancy

Allergic Reactions :

• COVID-19 vaccinations contain no latex, egg , or gelatin: persons with allergies to these items can receive the COVID-19 mRNA vaccinations without concern
• Allergic reactions not related to vaccines, injectable therapies, components of mRNA COVID-19 vaccines (including PEG), or polysorbates, such as food, pet, venom, or environmental allergies, or allergies to oral medications are NOT contraindications to vaccination with mRNA COVID-19 vaccines

V-Safe Application :

• Voluntary smartphone based tool
• Uses text messages and web surveys to provide real-time health check-ins after persons receive COVID-19 vaccinations
• Reports of adverse reactions may be followed up by CDC/V-Safe call centers to collect additional information if applicable